AABP EP Awards 728x90

NewLink gains fast-track support for Ebola vaccine

/wp-content/uploads/2022/11/BR_web_311x311.jpeg

Ames Tribune: Ames-based biopharmaceutical company NewLink Genetics has secured fast-track priority from U.S. and European drug regulators for a potential Ebola vaccine.